Search Results - "Azancot, Maria Antonieta"
-
1
Cardiorenal syndrome and diabetes: an evil pairing
Published in Frontiers in cardiovascular medicine (10-05-2023)“…Cardiorenal syndrome (CRS) is a pathology where the heart and kidney are involved, and the deterioration of one of them leads to the malfunction of the other…”
Get full text
Journal Article -
2
New aspects in cardiorenal syndrome and HFpEF
Published in Clinical kidney journal (01-10-2022)“…Cardiorenal syndrome (CRS) is a complex disease in which the heart and kidneys are simultaneously affected, and subsequently, the malfunction of one organ…”
Get full text
Journal Article -
3
A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score
Published in The Journal of infectious diseases (06-07-2020)“…Abstract Background We aimed at constructing a composite score based on Epstein-Barr virus DNAemia (EBVd) and simple clinical and immunological parameters to…”
Get full text
Journal Article -
4
Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience
Published in Journal of clinical medicine (21-03-2023)“…Vaccination is a known trigger for the appearance of immune-mediated glomerulopathies (IMG). The appearance of IMG after SARS-CoV-2 vaccination with suspected…”
Get full text
Journal Article -
5
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Published in The Lancet (British edition) (27-01-2024)“…Excess aldosterone accelerates chronic kidney disease progression. This phase 2 clinical trial assessed BI 690517, an aldosterone synthase inhibitor, for…”
Get full text
Journal Article -
6
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study
Published in Nephrology, dialysis, transplantation (31-03-2023)“…ABSTRACT Background There is scarce evidence on the fourth dose of severe acute respiratory syndrome coronavirus 2 vaccines in chronic kidney disease (CKD)…”
Get full text
Journal Article -
7
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study
Published in Nephrology, dialysis, transplantation (25-04-2022)Get full text
Journal Article